Skin Cancer Treated with Oncothermia and Intravenous Vitamin C

Skin Cancer Treated with Oncothermia and Intravenous Vitamin C

The following is a case report of a 75 year old male patient. The diagnosis is skin cancer. He was treated with oncothermia, combined with intravenous Vitamin C nutrition.

Diagnosis

In April 2019, the patient presented with skin cancer. In particular, a basal cell carcinoma on the left wing of the nose.

Basal cell carcinoma is the most common type of this cancer. It presents in the form of an ulcer with non-healing scabs that progressively increases in size. Treatment consists of surgical resection, leaving the margins free to avoid recurrence.

At the Oncothermia Unit in Barcelona we carry out coadjuvant treatment for these medical cases.

Treatment

Oncothermia and intravenous Vitamin C nutrition are recommended to reduce tumour volume.

Accordingly, she undergoes 15 60-minute Oncothermia sessions, with a frequency of 2 sessions per week, together with intravenous Vitamin C nutrition.

Result:

After completing the treatment the basal cell carcinoma disappeared completely.

If you wish, you can find more information about cancer treated with Oncotermia on our website, you can consult this link.

Malignant peripheral nerve sheath tumour treated with Oncothermia

Malignant peripheral nerve sheath tumour treated with Oncothermia

 

The following is the clinical case of a 70-year-old male patient. The diagnosis is malignant peripheral nerve sheath tumour in the left buttock. He was treated with radiotherapy, combined with oncothermia.

 

Diagnosis

In September 2012 he was diagnosed with a malignant peripheral nerve sheath tumour in the buttock.

 

Treatment

He received radiotherapy of 30 Gy in 10 fractions over 2 weeks in September 2012. Overall, after radiotherapy the tumour remained in progress for 2 months.

Oncothermia was started 2-3 times per week as an adjunct to radiotherapy.

 

Result

The tumour regressed with oncothermia treatment and this process continued gradually when oncothermia was maintained for 1 year.

 

 

(a) Radiotherapy treatment
(b) Radiation therapy and 24 sessions of Oncothermia
(c) Treatment with radiotherapy and 48 sessions of Oncothermia
(d) Treatment with radiotherapy and 72 sessions of Oncothermia
(e) Treatment with radiotherapy and 108 sessions of Oncothermia (1 year after starting treatment).

 

Reference

Jeung, T. , et al. (2015) Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma. Case Reports in Clinical Medicine, 4, 157-168. doi: 10.4236/crcm.2015.45033.

 

If you wish, you can find more information about clinical cases treated with Oncotermia on our website.

Stage IV Kidney Cancer treated by Oncothermia and herbs

Stage IV Kidney Cancer (Wilms Tumor) treated by Oncothermia and herbs

[message_box title=”Wilms tumour is the most common cause of kidney cancer in childhood and adolescence.” color=”red”]It also carries a mortality rate of 7-8 in one million. The 5-year survival rate for kidney cancer is 77.2 – 87.5%. When Wilms tumour progresses, radiotherapy and chemotherapy are conventionally used as the only treatments.[/message_box]

Clinical case

A 17-year-old Korean woman was treated from October 25, 2014, until July 22, 2015 with an integrating medical treatment, in order to control the extent of her illness.

The integrative medical treatment included: oncothermia, thymosin-α1 and phytotherapy. Phytotherapy was administered in 8 ml. of inhalation of Soram nebulizer solution qd, Soramdan S 8 g po, Hangamdan S 1 g po, tid, Cheongjangtang 10-30 ml, and Spiam HC 8 g po. She received Oncothermia (2-3 times a week) and 1.6 mg of treatment with thymosin-α1 (Zadaxin) i.m.

Result

According to the result of the CT on July 15, 2015, the liver metastasis was no longer seen, while the lung metastasis remained stable without tumor progression.

Conclusion

In patterns of Wilms tumor progression after surgery and chemotherapy, integrative medical treatment can be significant for disease control.

Reference

Lee D, Kim SS, Seong S, Cho W, Yu H. Stage IV Wilms Tumor Treated by Korean Medicine, Hyperthermia and Thymosin-α1: A Case Report. Case Rep Oncol. 2016 Feb 20;9(1):119-25. doi: 10.1159/000443724. 

If you wish, you can find more information about clinical cases treated with Oncotermia on our website.

Ascending colon cancer treated with Oncothermia and Chemotherapy

Ascending colon cancer treated with Oncothermia and Chemotherapy

The following is the clinical case of a 63-year-old male patient. The diagnosis is ascending colon cancer with liver metastases. He was treated with chemotherapy, combined with oncothermia.

Diagnosis

In November 2016, he presented with an ascending colon neoplasm. Consequently, he underwent a right hemicolectomy. As a result, the biopsy showed infiltrating adenocarcinoma.

Subsequently, in January 2017, she presented with elevated CEA. A CT scan revealed mesenteric and retroperitoneal lymphadenopathy. Multiple liver metastases were also observed, the largest measuring 35 mm.

Treatment

Immediately, in February 2017, he started treatment with chemotherapy (FOLFOX) and 4 sessions of 90-minute oncothermia.

The CT scan of April 2017 showed resolution of the mesenteric and retroperitoneal adenopathies. There was also a significant decrease in the multiple liver metastases, the largest being 14 mm.

Result

Finally a normalisation of tumour markers is detected.

If you wish, you can find more information about colon cancer treated with Oncothermia on our website at this link.

Breast Cancer treated with Chemotherapy and Oncothermia

Breast Cancer treated with Chemotherapy and Oncothermia

The following is the clinical case of a 51 year old female patient. The diagnosis is infiltrating ductal carcinoma of the left breast. She was treated with chemotherapy, combined with oncothermia.

Diagnosis

She presented in May 2016 with breast cancer, infiltrating ductal carcinoma of the left breast. Consequently, the MRI shows multiple and extensive irregular confluent foci. In addition, the cancer forms a mass measuring 79 mm x 52 mm x 58 mm extending to the nipple-areola complex with infiltration of the dermis.

Treatment

In June 2016 she started chemotherapy with Paclitaxel and Trastuzumab. Subsequently, in August 2016, oncothermia treatment was started, with 60-minute sessions.

Result

In October 2016 a breast MRI is performed for control, after the administration of 9 sessions of chemotherapy and 6 sessions of 60-minute oncothermia.

The result of the MRI shows disappearance of the tumour mass indicating a complete response to treatment.

Consequently, the patient refuses surgical treatment as there is no tumour mass and continues with radiological controls. In October 2018 the patient has shown no signs of recurrence.

If you wish, you can find more information about breast cancer treated with Oncothermia on our website at this link.

Clinical case: breast cancer treated with Oncothermia and surgery

CLINICAL CASE 3:

• BREAST CANCER
• ONCOTHERMIA+ SURGERY

A 41-year-old woman presented in June 2015 a palpable mass in the right breast of 9.3 mm. The biopsy in November 2015 shows infiltrating carcinoma. The patient, due to physical deterioration secondary to intermittent diarrhea of ​​8 years of evolution and phobia of aggressive medical treatments, decides not to do anything and returns to control it in October 2016 by magnetic resonance, whose result shows compatible image with neoformative infiltrating lobular process with nodular component of 16 mm x 9 mm and possible extension in the shape of the dough, reaching about 5 cm in diameter. The patient decides to treat with oncothermia and begins treatment in November 2016: 15 sessions of oncothermia of 1 hour. In February 2017, magnetic resonance was performed, showing a complete disappearance of the mass enhancement and a slight decrease in the nodular component: 15 mm x 8 mm. The patient decides to do nothing and check if there is growth by magnetic resonance every 6 months. Last resonance of July 2018, shows radiological stability and finally decides to undergo surgery to remove the tumor.

Pancreatic Cancer treated with Oncothermia, Chemotherapy and Radiotherapy

Pancreatic Cancer treated with Oncothermia, Chemotherapy and Radiotherapy

The following is a case report of a 72 year old female patient. The diagnosis is pancreatic cancer. She was treated with chemotherapy and radiotherapy, combined with oncothermia.

Diagnosis

She presented in March 2017 with a 4 cm tumour in the neck of the pancreas. In particular, the biopsy shows adenocarcinoma.

Treatment

He could not be resected surgically and started chemotherapy with Folfirinox together with 10 sessions of 90 minutes of Oncothermia.

Subsequently, in July 2017, a control CT scan was performed, showing a tumour reduction of 50%. He then started treatment with radiotherapy plus 10 sessions of 90-minute oncothermia.

Result

A new CT scan in June 2018 showed tumour stability with Ca 19-9 CEA tumour markers within normal limits.

If you wish, you can find more information about pancreatic cancer treated with Oncothermia on our website at this link.

Rectal cancer treated with oncothermia and surgery

Rectal Cancer treated with Oncothermia and Surgery

The following is a case report of a 67 year old male patient. The diagnosis is rectal cancer. He was treated with oncothermia and surgery.

Diagnosis

He presented with rectal adenocarcinoma in February 2018. In particular, it is a tumour 6 cm from the anal margin occupying one third of the intestinal lumen. In addition, the ultrasound scan showed serosal involvement, and it was classified as stage III.

Treatment

Preoperative chemotherapy and radiotherapy are recommended to reduce the tumour volume and perform surgical resection.

In this case, the patient categorically rejects chemotherapy and radiotherapy. On the contrary, he decided to start treatment with Oncothermia, with the aim of reducing the tumour volume and undergoing surgery.

He underwent 20 sessions of 90-minute oncothermia for 2 months, with a frequency of 3 sessions per week.

Result

Ultrasound endoscopy in May 2018 showed a T1 polypoid lesion. In September 2018 he underwent endoanal resection of the polypoid lesion with all the margins of the piece free of tumour.

If you wish, you can find more information about rectal cancer treated with Oncothermia on our website at this link.